Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Community news > Crick spinout to begin first-in-human clinical study for leukaemia

Crick spinout to begin first-in-human clinical study for leukaemia

GammaDelta Therapeutics has received Investigational New Drug approval from the US FDA for their GDX012 cell therapy to be investigated as a treatment for blood cancers. 
7 Jun 2021
United States of America
Community news

Featured

Clinicians

To view this News Article please log in or create a profile

Similar stories

Jake Cornwall Scoones, PhD student in the Developmental Dynamics Laboratory, has been awarded the prestigious fellowship… More...

Congratulations to Lucy, head of the Electron Microscopy STP, who has received the prestigious award for her long-standi… More...

Rory, a postdoctoral research assistant in the Developmental Dynamics Laboratory, has been awarded the Beddington Medal … More...

To mark World Hearing Day (3 March), the Enable Network is raising awareness about preventing deafness and hearing loss … More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk